Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009, 153(1):47-51 | DOI: 10.5507/bp.2009.008

BENEFITS OF THREE-MONTH CONTINUOUS GLUCOSE MONITORING FOR PERSONS WITH DIABETES USING INSULIN PUMPS AND SENSORS

Karolina Petersona, Jana Zapletalovab, Pavla Kudlovac, Veronika Matuskovaa, Josef Bartekd, Dalibor Novotnye, Rudolf Chlupa,f
a Department of Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
b Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc
c Department of Nursing, Faculty of Medicine and Dentistry, Palacky University Olomouc
d Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc
e Department of Clinical Biochemistry, University Hospital, Olomouc
f Department of Internal Medicine II, University Hospital Olomouc, I. P. Pavlova 6, 775 20 Olomouc

BACKGROUND: The latest Paradigm 722 insulin pump, Medtronic MiniMed, USA, enables daily reading of 288 interstitial fluid glucose concentrations determined by a sensor inserted into subcutaneous tissue; the sensor signals are transmitted into the insulin pump, enabling the patient to see real-time glucose concentration on the display and adapt further treatment.

AIMS: To assess the evolution of HbA1c over the course of a 3-month period in two cohorts of persons with type 1 (n=39) or type 2 (n=3) diabetes (PWD): 1) PWD on Paradigm 722 using sensors for continuous glucose monitoring (CGM group), 2) PWD on other types of insulin pumps performing intensive self-monitoring as before (3 to 6 times/d) on glucometer Linus, Wellion, Agamatrix (control group).

METHODS: Compliant PWDs using insulin pump with insulin aspart for several previous months were included in the study. Seventeen were put on Paradigm 722 with CGM and 25 were included in the control group. Paired t-test and the statistical program SPSS v.15.0 were used to analyze the data.

RESULTS: There was no significant difference in age between the two groups (P=0.996), in diabetes duration (P=0.482) or in daily insulin dose (P=0.469). In the CGM group (but not in the control group) HbA1c/IFCC dropped from 6.98±0.43 % to 5.98±0.36 % (P=0.006) within 1 month and remained reduced.

CONCLUSION: The use of the Paradigm 722 insulin pump with CGM resulted in significant improvement in HbA1c which appeared within one month and remained throughout the whole 3-month study period. No significant improvement in HbA1c was seen in the control group.

Keywords: Insulin pump, Continuous glucose monitoring, Glucometer, Diabetes mellitus, Insulin, Haemoglobin A1c, Diabetes education

Received: October 16, 2008; Accepted: November 14, 2008; Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Peterson, K., Zapletalova, J., Kudlova, P., Matuskova, V., Bartek, J., Novotny, D., & Chlup, R. (2009). BENEFITS OF THREE-MONTH CONTINUOUS GLUCOSE MONITORING FOR PERSONS WITH DIABETES USING INSULIN PUMPS AND SENSORS. Biomedical papers, 153(1), 47-51. doi: 10.5507/bp.2009.008
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kudlova P, Chlup R. Self-monitoring u osob s diabetem. Interni Med 2006; 8(12): 539-544.
    2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593598. Go to original source... Go to PubMed...
    3. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 1990; 13: 10441050. Go to original source... Go to PubMed...
    4. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422425. Go to original source... Go to PubMed...
    5. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006; 29: 17641770. Go to original source... Go to PubMed...
    6. Farmer A, Wade A, Goyder E, Yudkin P, French D, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 132139. Go to original source... Go to PubMed...
    7. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab 1989; 15: 255260.
    8. Garg SK. Glucose Monitoring: An important Tool for Improving Glucose Control and Reducing Hypoglycemia. Diab Technol Therap 2008; 10 (1):14. Go to original source...
    9. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, et al. Selfmonitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587 594. Go to original source...
    10. Heinemann L, Koschinsky T. Clinical Application and Challenges of Blood Glucose Measurement Technology for Self-Monitoring. Diab Technol Therap 2008; 10 (1): 2734. Go to original source...
    11. Nielsen JK, Gravholt CH, Djurhuus CHB, Brandt D, Becker J, Heinemann L, Christiansen JS. Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c. J Diab Sci Tech 2007; 1(6):857963. Go to original source...
    12. Schwedes U, Siebolds M, Mertes G. Meal-related structured selfmonitoring of blood glucose: effect on diabetes control in noninsulin- treated type 2 diabetic patients. Diabetes Care 2002; 25: 19281932. Go to original source... Go to PubMed...
    13. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 15101517. Go to original source... Go to PubMed...
    14. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271278. Go to original source... Go to PubMed...
    15. Owens DR, Barnett AH, Pickup JC, Kerr D, Bushby P, et al. Blood glucose monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary Care 2004; 6: 816.
    16. Schiffrin A, Belmonte M. Multiple daily selfglucose monitoring: its essential role in long term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1981; 4: 595600. Go to original source... Go to PubMed...
    17. DCCT Research Group. Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 1987; 10: 119. Go to original source...
    18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977986. Go to original source...
    19. Hirsch IB, Amstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H. Clinical Application of Emerging Sensor Technologies in Diabetes Management: Concensus Guidelines for Continuous Glucose Monitoring (CGM). Diab Technol Therap 2008; 10(4): 232246. Go to original source...
    20. Mlcak P, Fialova J, Trnkova K, Chlup R. A continuous glucose monitoring system (CGMS) A promising approach for improving metabolic control in person with type 1 diabetes mellitus treated by insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep 2004; 148: 3338. Go to original source... Go to PubMed...
    21. Chlup R, Jelenová D, Chlupová K, Zapletalová J, Chlupová L, Bartek J. Function and accuracy of glucose sensors beyond their stated expiry date. Diab Technol Therap 2006; 8(4): 495504. Go to original source... Go to PubMed...
    22. Chlup R, Peterson K, Zapletalova J, Langova K, Kudlova P, Pribylova H, Matuskova V. Relation between HbA1c and Average One-Month Interstitial Fluid Glucose Concentration (ISFG) Determined by Continuous Glucose Monitoring Preliminary Results of an Ongoing Study. Diabetes 2007; 56 (Suppl 1):A 527 (Abstract 2083-PO).
    23. Jeha GS, Karaviti LP, Anderson B, Smith FO, Donaldson S, McGirk TS, Haymond MW. Insulin pump therapy in preschool children with type 1 diabetes mellitus improved glycemic control and decreases glucose excursion and the risk of hypoglycemia. Diab Technol Ther 2005; 7: 876884. Go to original source... Go to PubMed...
    24. Deiss D, Bolinder J, Riveline JP, Battelino T, Bost E, Tubiana- Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diab Care 2006; 29 (12): 27302732. Go to original source... Go to PubMed...
    25. Chlup R, Zapletalova J, Seckar P, Chlupova L, Tancosova S, Reznickova M. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump. Biomed Papers 2004; 148(1): 2732. Go to original source...
    26. Melku V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L, Blin P, Augendre-Ferrante B, Tauber JP. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 1998; 21: 977982. Go to original source... Go to PubMed...
    27. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin ChG, Wolpert HA, Buckingham BA. Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study. Diab Technol Therap 2008; 10(5): 377383. Go to original source...
    28. Chlupová K, Kohnert KD, Heinke P, Augstein P, Chlup R, Salzsieder E. Resultate kontinuerlicher Glukosemessungen (CGMS) unter ambulanten Bedingungen zur Beurteilung der Stoffwechseleinstellung bei T2DM. Diabetologie und Stoffwechsel 2006; 1 (1): 94(Abstract). Go to original source...
    29. Klonoff DC. The benefits of implanted glucose sensors. J Diab Sci Tech 2007; 1(6): 797800. Go to original source...
    30. Lee SW., Sweeney T, Clausen D, Kolbach C, Haasen A, Firek A, Brinegar Ch, Petrofsky J. Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump nave patients with type 1 diabetes; Single center pilot study experience. J Diab Sci Tech 2007; 1(3):400-404. Go to original source...
    31. Peterson K, Chlup R, Langova K, Zapletalova J, Kudlova P, Pribylova H. Benefits of continuous glucose monitoring transmitted to Paradigm 722. Diabetes 2007; 56 (Suppl 1):A531 (Abstract 2099-PO).
    32. Langova K, Pribylova H, Kajabova M, Luza J. Assessment of haemoglobin A1c evolution using various statistical methods (survival analysis and linear regression) in persons with diabetes mellitus. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2008; 152 (2): submitted. Go to original source...
    33. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1cindependent risk factor for diabetic complications. JAMA 2006; 295: 17071708. Go to original source... Go to PubMed...
    34. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diab Complic 2005; 19: 178181. Go to original source... Go to PubMed...
    35. Home PD. Special Article For Debate. HbA1c: the case for using estimated average glucose (eAG). Diab Med 2008; 25: 895-898. Go to original source... Go to PubMed...
    36. Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson Ch, Ellis SL, Gutin RS, Gottlieb PA. Improved Glycemic Control in Intensively Treated Adult Subjects with Type 1 Diabetes Using Insulin Guidance Software. Diab Technol Therap 2008; 10 (5): 369375. Go to original source...
    37. Mazze R. The Future of Self-Monitored Blood Glucose: Mean Blood Glucose versus Glycosylated Heboglobin. Diab Technol Therap 2008; 10(1): 93101. Go to original source... Go to PubMed...
    38. Clarke WL, Kovatchev B. Continuous glucose sensors: continuing questions about clinical accuracy. J Diab Sci Tech 2007; 1(3): 669675. Go to original source...
    39. Mastrototaro J, Shin J, Marcus A, Sulur G. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes. Diab Technol Therap 2008; 10 (5): 385390. Go to original source...
    40. Mastrototaro J, Soundararajan G, Cooper K, Shah R. Accuracy of Real-Tima Continuous Glucose Monitoring in the MiniMed Paradigm System. Diabetes 2007; 56(Suppl1): A 112 (P422). Go to PubMed...
    41. Jadviscokova T, Fajkusova Z, Pallayova M, Luza J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2007; 151 (2): 263266. Go to original source...
    42. Skyler JA. CGM a technology in evolution. Diab Technol Therap 2009;11(2):6364. Go to original source...
    43. Lippaiova N, Pallayova M, Kuzmina G, Peterson K, Fajkosova L, Luza J. Safety of new algorithms for premeal insulin boluses in high glycemic index meals in persons with type 1 diabetes mellitus using insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2008; 152 (1): 7378. Go to original source... Go to PubMed...
    44. Pribylova H, Pallayova M, Hucikova J, Luza J. Evaluation of the new software program DegifXL4 in the determination of the glycemic indices of foodstuffs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2008; 152 (1): 6572. Go to original source... Go to PubMed...
    45. Fajkusova Z, Jadviscokova T, Pallayova M, Matuskova V, Luza J, Kuzmina G. Glycaemic index of selected foodstuffs in healthy persons. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(2):257-261. Go to original source... Go to PubMed...

    Return to the content